Parkinson's disease (Q28264391)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Parkinson's disease	scientific article

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Parkinson's disease (English)

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

object named as

Bruce R Ransom

3

0 references

2

object named as

John G Nutt

0 references

author name string

Ali Samii

1

0 references

language of work or name

0 references

publication date

29 May 2004

0 references

0 references

363

0 references

1783-93

0 references

9423

0 references

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Lumping and splitting the Parkinson Plus syndromes: dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Onset age of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Early onset Parkinson's disease: are juvenile- and young-onset different?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Young-onset Parkinson's disease: a clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Autonomic dysfunctions in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence, etiology, and treatment of depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Painful Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Sleep disorders in Parkinson's disease: epidemiology and management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Criteria for diagnosing Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic criteria for Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential diagnosis of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopa-responsive dystonia: recent advances and remaining issues to be addressed.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Huntington disease in children: genotype-phenotype correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Normal aging of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of parkinsonian signs and associated mortality in a community population of older people.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Aging and Extrapyramidal Function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Essential tremor and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-Induced Movement Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive supranuclear palsy: clinical features, pathophysiology and management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Corticobasal degeneration. A clinical study of 36 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Consensus statement on the diagnosis of multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical Lewy body syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular parkinsonism: a distinct, heterogeneous clinical entity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular parkinsonism: a review of the precision and frequency of the diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

[123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Do dopamine agonists or levodopa modify Parkinson's disease progression?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine agonist monotherapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of dopamine transporter imaging in routine clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuropathology of autonomic nervous system in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Etiology of Parkinson's disease: Genetics and environment revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Striatal 18F-dopa uptake: absence of an aging effect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased risk of Parkinson's disease in parents and siblings of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Parkinson's disease in 65 pairs of twins and in a set of quadruplets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Parkinson's disease in a nationwide twin cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Parkinson's disease in twins studied with 18F-dopa and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Parkinson disease in twins: an etiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetics of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of the ubiquitin-proteasome system in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between early-onset Parkinson's disease and mutations in the parkin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Complex relationship between Parkin mutations and Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The ubiquitin pathway in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of the neurotoxicity of MPTP. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Environmental risk factors and Parkinson's disease: a metaanalysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of coffee and caffeine intake with the risk of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasion of brain by neurovirulent influenza A virus after intranasal inoculation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Occupational risk factors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Influenza virus antigen in postencephalitic parkinsonism brain. Detection by immunofluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Postencephalitic parkinsonism--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha-synuclein and neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired clearance of oxidised proteins in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein nitration in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment interventions for Parkinson's disease: an evidence based assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional recovery in parkinsonian monkeys treated with GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Valvular heart disease in patients taking pergolide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the Risk of Adverse Events with Pramipexole and Ropinirole in Patients with Parkinson???s Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Motor fluctuations and dyskinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immediate-release and controlled-release carbidopa/levodopa in PD: a 5-year randomized multicenter study. Carbidopa/Levodopa Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Young-onset Parkinson's disease revisited--clinical features, natural history, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolcapone and fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

N-Methyl-d-Aspartate Antagonists in the Treatment of Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Levodopa therapy: consequences of the nonphysiologic replacement of dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of psychosis in Parkinson's disease: safety considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A Brief History of Pallidotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalamotomy for movement disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson's disease: neuropsychological and neurological side effects. Report of four cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Complications of deep brain stimulation surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bilateral high-frequency stimulation of the internal globus pallidus in advanced Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Stem cells in the treatment of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916305-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(04)16305-8

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28264391&oldid=1985114498"